SIE 0.00% 6.8¢ scigen limited

new substantial holder, page-11

  1. M1
    493 Posts.
    re: looking good for 2006 Launch of scilin (insulin) product is due this month in Philippines. Soon after that, in Thailand. Pol


    09:11, Monday, 14 November 2005

    Sydney - Monday - November 14: (RWE Australian Business News) -
    SciGen Ltd (ASX code: SIE) has received a licence to market its insulin
    product SciLin in the Kingdom of Thailand.
    According to the World Health Organisation, more than 3.5
    Million Thais are diagnosed with diabetes and a large number of the
    population remains undiagnosed.
    The insulin pharmaceutical market in Thailand is estimated to be
    $US15 million.
    This market is presently shared by two multinational companies.
    Preparations are under way for the launch of SciLin in Thailand
    early next year.
    SciLin is currently registered and sold by SciGen or its
    partners in India, Vietnam and Pakistan, and will soon be launched in
    the Philippines.
    Shares in SciGen fell 0.1c to 7.2c on Friday.
    ENDS

 
watchlist Created with Sketch. Add SIE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.